Sohini Das &Amp; Samreen Ahmad

Stories by Sohini Das &Amp; Samreen Ahmad

Covaxin: How Bharat Biotech plans to boost immunity

Covaxin: How Bharat Biotech plans to boost immunity

Rediff.com   6 Oct 2020

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com   6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com   6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Silver Lake's love affair with India continues

Silver Lake's love affair with India continues

Rediff.com   25 Sep 2020

The PE biggie has committed to pumping money into Jio Platforms, Byju's and Reliance Retail so far this year - all marquee names in their respective sectors.

Covid spurs matured-stage start-ups to advance their IPO plans

Covid spurs matured-stage start-ups to advance their IPO plans

Rediff.com   25 Sep 2020

In the past few days, many companies, including fashion e-tailer Nykaa, food delivery platform Zomato, logistics and delivery firm Delhivery, insurance discovery platform PolicyBazaar, eyewear retail chain Lenskart, and edtech and online tutoring firm Byju's, have openly spoken about their IPO plans.

How India is gearing up to distribute Covid-19 vaccine

How India is gearing up to distribute Covid-19 vaccine

Rediff.com   18 Sep 2020

A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains.

Tiger Global, others invest $225 mn in parent of IPL title sponsor Dream11

Tiger Global, others invest $225 mn in parent of IPL title sponsor Dream11

Rediff.com   15 Sep 2020

The new round values the company at $2.5 billion, more than double the over $1 billion valuation Dream 11 enjoyed in April 2019 when it was declared the country's first gaming unicorn.

How Covid has triggered wave of innovations in India

How Covid has triggered wave of innovations in India

Rediff.com   14 Sep 2020

Some of these items of consumption include ultraviolet disinfectants and sanitising boxes, free-finger touch devices, do-it-yourself grooming kits, self-cleaning water bottles, smart tiffin boxes, hand-sanitizer wearables, antiviral fabrics, tiles, flooring and mattresses, and anti-fogging glasses.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com   14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

Post sale of Future group, Biyani will keep home retailing biz going

Post sale of Future group, Biyani will keep home retailing biz going

Rediff.com   11 Sep 2020

Future's home retailing interests, including furniture and furnishings, are housed under Praxis Home Retail, which was created in FY18 when the group demerged the business from Future Retail.

India will wait for DCGI nod to restart Oxford vaccine trial

India will wait for DCGI nod to restart Oxford vaccine trial

Rediff.com   11 Sep 2020

The global trials were halted after a study participant suffered a 'potentially unexplained illness, reports Sohini Das.

PUBG Mobile sheds China link to woo Indian gamers

PUBG Mobile sheds China link to woo Indian gamers

Rediff.com   9 Sep 2020

Even though PUBG Corporation is a South Korean company with its headquarters in Seoul, Tencent Gaming, a subsidiary of Chinese investment and technology giant Tencent, holds the global franchise for the mobile version of the game.

Edtech start-up Eruditus gets funding from Zuckerberg duo

Edtech start-up Eruditus gets funding from Zuckerberg duo

Rediff.com   7 Sep 2020

Eruditus runs on a partnership model with top global universities such as MIT, Columbia, Harvard, Cambridge, INSEAD, Wharton, and UC Berkeley, offering courses in coding, data science, fintech, block chain, and entrepreneurship.

With coronavirus still around, 'virus killers' hit the market

With coronavirus still around, 'virus killers' hit the market

Rediff.com   7 Sep 2020

A gamechanger for offices and factories, Shycocan, claims to be able to clear an area of 1000 square feet from coronavirus.

Can Gondal's FAU-G tackle PUBG's withdrawal pangs?

Can Gondal's FAU-G tackle PUBG's withdrawal pangs?

Rediff.com   5 Sep 2020

According to nCore Games, FAU-G will be based on real scenarios encountered by the Indian security forces to deal with both domestic and foreign threats, with its first level set against the Galwan Valley backdrop. The start-up is planning to monetise the venture through in-game purchase where people will be able to buy better items in the game like better armour for an enhanced gaming experience.

In the works: Priority list of who will get Covid vaccine first

In the works: Priority list of who will get Covid vaccine first

Rediff.com   4 Sep 2020

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com   2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Pandemic brings windfall for e-pharma companies

Pandemic brings windfall for e-pharma companies

Rediff.com   27 Aug 2020

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.

How India's healthcare system will change forever

How India's healthcare system will change forever

Rediff.com   27 Aug 2020

The National Digital Health Mission seeks to provide a unique health ID to each citizen who wishes to have one and also on-board the healthcare service provides - hospitals, pharmacies and diagnostic labs, among others. It will have an online database of doctors and personal health records.

'Cipla has emerged as a great catchment area for talent'

'Cipla has emerged as a great "catchment area" for talent'

Rediff.com   20 Aug 2020

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.